Medical Properties Trust annual debt-to-ebitda ratio
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Medical Properties Trust Debt-to-EBITDA Ratio Growth & History (MPT)
Medical Properties Trust's debt-to-ebitda ratio was 32.33 for fiscal 2025.
View full Medical Properties Trust company overviewMedical Properties Trust annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 32.33 | 11.21 | +53.09% |
| 2024 | 2024-12-31 | 21.12 | −14.40 | −40.55% |
| 2023 | 2023-12-31 | 35.52 | 25.05 | +239.14% |
| 2022 | 2022-12-31 | 10.47 | −0.84 | −7.41% |
| 2021 | 2021-12-31 | 11.31 | −0.24 | −2.04% |
| 2020 | 2020-12-31 | 11.55 | −2.65 | −18.66% |
| 2019 | 2019-12-31 | 14.20 | 5.78 | +68.59% |
| 2018 | 2018-12-31 | 8.42 | 0.49 | +6.17% |
| 2017 | 2017-12-31 | 7.93 | 1.31 | +19.76% |
| 2016 | 2016-12-31 | 6.62 | −3.37 | −33.73% |
| 2015 | 2015-12-31 | 9.99 | −1.11 | −9.96% |
| 2014 | 2014-12-31 | 11.10 | 3.71 | +50.19% |
| 2013 | 2013-12-31 | 7.39 | 1.19 | +19.28% |
| 2012 | 2012-12-31 | 6.20 | −0.33 | −5.10% |
| 2011 | 2011-12-31 | 6.53 | 1.13 | +20.93% |
| 2010 | 2010-12-31 | 5.40 | — | — |
Medical Properties Trust quarterly debt-to-ebitda ratio
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 21.05 | −10.28 | −32.80% |
| Q1 2026 | 2026-03-31 | 29.96 | 3.41 | +12.86% |
| Q4 2025 | 2025-12-31 | 32.33 | 11.21 | +53.09% |
| Q3 2025 | 2025-09-30 | 33.33 | −86.24 | −72.12% |
| Q2 2025 | 2025-06-30 | 31.32 | −29.36 | −48.39% |
| Q1 2025 | 2025-03-31 | 26.54 | −22.75 | −46.15% |
| Q4 2024 | 2024-12-31 | 21.12 | −14.40 | −40.55% |
| Q3 2024 | 2024-09-30 | 119.58 | 106.59 | +821.06% |
| Q2 2024 | 2024-06-30 | 60.69 | 48.58 | +401.38% |
| Q1 2024 | 2024-03-31 | 49.29 | 38.01 | +337.09% |
| Q4 2023 | 2023-12-31 | 35.52 | 25.05 | +239.14% |
| Q3 2023 | 2023-09-30 | 12.98 | 3.71 | +40.01% |
| Q2 2023 | 2023-06-30 | 12.10 | 2.50 | +26.09% |
| Q1 2023 | 2023-03-31 | 11.28 | 1.55 | +15.90% |
| Q4 2022 | 2022-12-31 | 10.47 | −0.84 | −7.41% |
| Q3 2022 | 2022-09-30 | 9.27 | −1.94 | −17.32% |
| Q2 2022 | 2022-06-30 | 9.60 | −1.56 | −13.98% |
| Q1 2022 | 2022-03-31 | 9.73 | −2.24 | −18.70% |
| Q4 2021 | 2021-12-31 | 11.31 | −0.24 | −2.04% |
| Q3 2021 | 2021-09-30 | 11.21 | −0.30 | −2.59% |
| Q2 2021 | 2021-06-30 | 11.16 | −1.12 | −9.12% |
| Q1 2021 | 2021-03-31 | 11.97 | −1.45 | −10.78% |
| Q4 2020 | 2020-12-31 | 11.55 | −2.65 | −18.66% |
| Q3 2020 | 2020-09-30 | 11.51 | −1.93 | −14.38% |
| Q2 2020 | 2020-06-30 | 12.28 | 1.05 | +9.37% |
| Q1 2020 | 2020-03-31 | 13.41 | 4.37 | +48.30% |
| Q4 2019 | 2019-12-31 | 14.20 | 5.78 | +68.59% |
| Q3 2019 | 2019-09-30 | 13.45 | 6.12 | +83.62% |
| Q2 2019 | 2019-06-30 | 11.23 | 2.97 | +36.03% |
| Q1 2019 | 2019-03-31 | 9.05 | 0.98 | +12.12% |
| Q4 2018 | 2018-12-31 | 8.42 | 0.49 | +6.17% |
| Q3 2018 | 2018-09-30 | 7.32 | −1.71 | −18.96% |
| Q2 2018 | 2018-06-30 | 8.25 | 1.73 | +26.58% |
| Q1 2018 | 2018-03-31 | 8.07 | 0.87 | +12.10% |
| Q4 2017 | 2017-12-31 | 7.93 | 1.31 | +19.76% |
| Q3 2017 | 2017-09-30 | 9.04 | 2.95 | +48.54% |
| Q2 2017 | 2017-06-30 | 6.52 | −0.14 | −2.08% |
| Q1 2017 | 2017-03-31 | 7.20 | −1.82 | −20.16% |
| Q4 2016 | 2016-12-31 | 6.62 | −3.37 | −33.73% |
| Q3 2016 | 2016-09-30 | 6.08 | −6.30 | −50.89% |
| Q2 2016 | 2016-06-30 | 6.66 | −2.01 | −23.16% |
| Q1 2016 | 2016-03-31 | 9.01 | 0.99 | +12.31% |
| Q4 2015 | 2015-12-31 | 9.99 | −1.11 | −9.96% |
| Q3 2015 | 2015-09-30 | 12.39 | 3.95 | +46.82% |
| Q2 2015 | 2015-06-30 | 8.67 | −0.73 | −7.78% |
| Q1 2015 | 2015-03-31 | 8.03 | 0.10 | +1.23% |
| Q4 2014 | 2014-12-31 | 11.10 | 3.71 | +50.19% |
| Q3 2014 | 2014-09-30 | 8.44 | 2.85 | +50.91% |
| Q2 2014 | 2014-06-30 | 9.40 | 4.52 | +92.62% |
| Q1 2014 | 2014-03-31 | 7.93 | 3.05 | +62.52% |
| Q4 2013 | 2013-12-31 | 7.39 | 1.19 | +19.28% |
| Q3 2013 | 2013-09-30 | 5.59 | −1.57 | −21.98% |
| Q2 2013 | 2013-06-30 | 4.88 | −2.26 | −31.71% |
| Q1 2013 | 2013-03-31 | 4.88 | −3.28 | −40.17% |
| Q4 2012 | 2012-12-31 | 6.20 | −0.33 | −5.10% |
| Q3 2012 | 2012-09-30 | 7.16 | 0.20 | +2.84% |
| Q2 2012 | 2012-06-30 | 7.14 | −1.12 | −13.59% |
| Q1 2012 | 2012-03-31 | 8.15 | 2.30 | +39.23% |
| Q4 2011 | 2011-12-31 | 6.53 | 1.13 | +20.93% |
| Q3 2011 | 2011-09-30 | 6.97 | — | — |
| Q2 2011 | 2011-06-30 | 8.27 | — | — |
| Q1 2011 | 2011-03-31 | 5.86 | — | — |
| Q4 2010 | 2010-12-31 | 5.40 | — | — |
Medical Properties Trust debt-to-ebitda ratio trends
Over the last five fiscal years, Medical Properties Trust's debt-to-ebitda ratio increased from 11.55 to 32.33, a change of 20.78. The latest reported quarter, Q2 2026, shows 21.05.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medical Properties Trust source filings ↗